North America Microfluidics Market Size & Outlook

The microfluidics market in North America is expected to reach a projected revenue of US$ 27,852.9 million by 2030. A compound annual growth rate of 10.6% is expected of North America microfluidics market from 2024 to 2030.
Revenue, 2023 (US$M)
$13,723.2
Forecast, 2030 (US$M)
$27,852.9
CAGR, 2024 - 2030
10.6%
Report Coverage
North America

North America microfluidics market highlights

  • The North America microfluidics market generated a revenue of USD 13,723.2 million in 2023.
  • The market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
  • In terms of segment, medical was the largest revenue generating technology in 2023.
  • Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 13,723.2 million
Market revenue in 2030USD 27,852.9 million
Growth rate10.6% (CAGR from 2023 to 2030)
Largest segmentMedical
Fastest growing segmentMedical
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMedical, Non-Medical
Key market players worldwideIllumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 42.7% of the global microfluidics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 18,147.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Microfluidics Market Companies

Name Profile # Employees HQ Website

North America microfluidics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.


Medical was the largest segment with a revenue share of 83.98% in 2023. Horizon Databook has segmented the North America microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.


North America accounted for the largest revenue share in 2021. An increase in research funding from government organizations and industries is the major factor driving the market growth. The demand for microfluidics devices in the research and diagnostics field has spurred industry-academia collaboration to accelerate the commercialization of lab-built devices.

For instance, in July 2020, Fluidigm Corporation executed a letter contract with the National Institute of Biomedical Imaging and Bioengineering and the National Institutes of Health for the Rapid Acceleration of Diagnostics program. This funding was expected to bring the benefit of advanced micro- and nanotechnology to patients globally.

Reasons to subscribe to North America microfluidics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America microfluidics market databook

  • Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America microfluidics market , including forecasts for subscribers. This continent databook contains high-level insights into North America microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America microfluidics market size, by country, 2018-2030 (US$M)

North America Microfluidics Market Outlook Share, 2023 & 2030 (US$M)

North America microfluidics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more